Vera Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -5155%. Total operating expenses were $102,012,000.

Profit Margin

Vera Therapeutics, Inc. (NASDAQ:VERA): Profit margin
2019 0 -11.85M
2020 0 -53.41M
2021 0 -32.60M
2022 0 -89.05M
2023 1.86M -95.99M -5155.21%

VERA Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
1.86M0000
Cost of revenue
0-846K176K251K509K
Gross profit
1.86M846K-176K-251K-509K
Operating exp.
Research and development
78.22M68.99M22.48M45.20M7.29M
Selling and marketing
00000
Total operating expenses
102.01M90.90M34.40M49.24M11.7M
Operating income
-102.01M-90.90M-34.40M-52.24M-11.96M
Other income (expenses), net
6.02M1.84M1.79M-1.17M108K
Income before tax
-95.98M-89.05M-32.60M-53.41M-11.85M
Income tax expense
1K1K1K1K1K
Net income
-95.99M-89.05M-32.60M-53.41M-11.85M
Earnings per share
Basic EPS
-2.25-3.35-1.53-14.4-3.46
Diluted EPS
-2.25-3.35-1.53-14.4-3.46
Data sourceData sourceData source